Transcript 4-24-15_11 - Community Oncology Alliance

Community Oncology Conference
Ricky Newton, CPA
Director of Financial Services and Operations and Treasurer
April 24, 2015
Background
▪ 25-35% of all new drugs being made for oncology
patients are coming out as oral drugs
▪ Patients need a safe, reliable, accessible and
affordable environment that is tightly integrated into
their overall cancer care
▪ Community clinics over the years have opened up
facilities within their clinics to provide these services
instead of the patients having to rely on specialty
pharmacies and other retail pharmacies
70 Oncology Oral Drugs
© 2015 Community Oncology Alliance
3
Oral Drugs Classified by Indication
© 2015 Community Oncology Alliance
4
© 2015 Community Oncology Alliance
5
COPA Mission
▪ Foster oral cancer therapy tightly integrated into cancer patient
treatment at the site of care. Specifically, COPA will:
• Help practices enhance outcomes of cancer patients treated with oral
medications
▸Focus on quality, efficiency, and financial viability
• Establish quality standards, best practice benchmarks, operating
•
•
•
procedures, and other clinical/operating processes
Provide a forum for practices to share best practices and information,
especially relating to state pharmacy issues
Develop the quality/value proposition of “integrated oral cancer
treatment” for payers (Medicare, private, self insured)
Educate pharmaceutical companies on the clinical/value proposition of
“integrated oral cancer treatment”
© 2015 Community Oncology Alliance
6
Examples of Specialty Pharmacies
© 2015 Community Oncology Alliance
7
Immediate Priorities
▪ Create standard national quality measures
▪ Establish a way to measure quality in a tangible way
• Similar to the oncology medical home initiative
▪ Publish an independent report/analysis documenting
patient experience of receiving oral cancer drugs in
practice versus specialty pharmacy
▪ Develop the COPA website
▪ Create information sharing on the closed COPA list serve
© 2015 Community Oncology Alliance
8
Priorities Specific to Patients
▪ Library of patient assistant programs for all oral chemotherapy
and supportive care drugs
▪ Library of patient focused educational materials on each oral
drug
▪ Patient focused educational material highlighting a practice’s
dispensing program
▪ Blog for patients to be able to ask questions of other patients
on oral drugs or the ability to write their stories and
experiences to share with other
9
▪ Story of my brother in law’s wife’s mother with Thalidomide for
multiple myeloma over 15 years ago
▪ Rose will be following up with each of you in the next session
about how to jump on board and help us initiate this effort